New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:40 EDTMDXGMiMedx EpiFix allograft awarded coverage by HCSC
MiMedx Group announced that Health Care Services Corporation, HCSC, has confirmed that the company's EpiFix allograft has been awarded reimbursement coverage. HCSC has approved the reimbursement of EpiFix for the indications as prescribed by the physician, including wound care, soft tissue replacement or repairs in burns, cardiovascular applications, treatment of ocular surfaces, and the application as a surgical barrier in knee or spine surgeries. The company also reported that its EpiFix allograft currently has reimbursement approval from 12 state Medicaid Programs.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
07:45 EDTMDXGMiMedx upside seen in new markets, says Canaccord
Subscribe for More Information
February 26, 2015
07:36 EDTMDXGMiMedx backs FY15 revenue view $175M-$190M, consensus $183.61M
Subscribe for More Information
07:36 EDTMDXGMiMedx backs Q1 revenue view $40M-$41M, consensus $40.54M
Subscribe for More Information
07:34 EDTMDXGMiMedx reports Q4 EPS 3c, consensus 3c
Subscribe for More Information
February 20, 2015
10:01 EDTMDXGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:17 EDTMDXGMiMedx upgraded to Strong Buy with $13 target at Needham
Needham upgraded MiMedx to Strong Buy from Buy saying it has renewed confidence the company can exceed consensus 2015 estimates after meeting with management. The firm has a $13 price target for shares.
06:45 EDTMDXGMiMedx upgraded to Strong Buy from Buy at Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use